Cargando…
Prophylactic effect of intravenous lidocaine against cognitive deficit after cardiac surgery: A PRISMA-compliant meta-analysis and trial sequential analysis
This study aimed at providing an updated evidence of the association between intraoperative lidocaine and risk of postcardiac surgery cognitive deficit. METHODS: Randomized clinical trials (RCTs) investigating effects of intravenous lidocaine against cognitive deficit in adults undergoing cardiac su...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439840/ https://www.ncbi.nlm.nih.gov/pubmed/36107567 http://dx.doi.org/10.1097/MD.0000000000030476 |
_version_ | 1784782167402872832 |
---|---|
author | Hung, Kuo-Chuan Ho, Chun-Ning Liu, Wei-Cheng Yew, Ming Chang, Ying-Jen Lin, Yao-Tsung Hung, I-Yin Chen, Jen-Yin Huang, Ping-Wen Sun, Cheuk-Kwan |
author_facet | Hung, Kuo-Chuan Ho, Chun-Ning Liu, Wei-Cheng Yew, Ming Chang, Ying-Jen Lin, Yao-Tsung Hung, I-Yin Chen, Jen-Yin Huang, Ping-Wen Sun, Cheuk-Kwan |
author_sort | Hung, Kuo-Chuan |
collection | PubMed |
description | This study aimed at providing an updated evidence of the association between intraoperative lidocaine and risk of postcardiac surgery cognitive deficit. METHODS: Randomized clinical trials (RCTs) investigating effects of intravenous lidocaine against cognitive deficit in adults undergoing cardiac surgeries were retrieved from the EMBASE, MEDLINE, Google scholar, and Cochrane controlled trials register databases from inception till May 2021. Risk of cognitive deficit was the primary endpoint, while secondary endpoints were length of stay (LOS) in intensive care unit/hospital. Impact of individual studies and cumulative evidence reliability were evaluated with sensitivity analyses and trial sequential analysis, respectively. RESULTS: Six RCTs involving 963 patients published from 1999 to 2019 were included. In early postoperative period (i.e., 2 weeks), the use of intravenous lidocaine (overall incidence = 14.8%) was associated with a lower risk of cognitive deficit compared to that with placebo (overall incidence = 33.1%) (relative risk = 0.49, 95% confidence interval: 0.32–0.75). However, sensitivity analysis and trial sequential analysis signified insufficient evidence to arrive at a firm conclusion. In the late postoperative period (i.e., 6–10 weeks), perioperative intravenous lidocaine (overall incidence = 37.9%) did not reduce the risk of cognitive deficit (relative risk = 0.99, 95% confidence interval: 0.84) compared to the placebo (overall incidence = 38.6%). Intravenous lidocaine was associated with a shortened LOS in intensive care unit/hospital with weak evidence. CONCLUSION: Our results indicated a prophylactic effect of intravenous lidocaine against cognitive deficit only at the early postoperative period despite insufficient evidence. Further large-scale studies are warranted to assess its use for the prevention of cognitive deficit and enhancement of recovery (e.g., LOS). |
format | Online Article Text |
id | pubmed-9439840 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94398402022-09-06 Prophylactic effect of intravenous lidocaine against cognitive deficit after cardiac surgery: A PRISMA-compliant meta-analysis and trial sequential analysis Hung, Kuo-Chuan Ho, Chun-Ning Liu, Wei-Cheng Yew, Ming Chang, Ying-Jen Lin, Yao-Tsung Hung, I-Yin Chen, Jen-Yin Huang, Ping-Wen Sun, Cheuk-Kwan Medicine (Baltimore) Research Article This study aimed at providing an updated evidence of the association between intraoperative lidocaine and risk of postcardiac surgery cognitive deficit. METHODS: Randomized clinical trials (RCTs) investigating effects of intravenous lidocaine against cognitive deficit in adults undergoing cardiac surgeries were retrieved from the EMBASE, MEDLINE, Google scholar, and Cochrane controlled trials register databases from inception till May 2021. Risk of cognitive deficit was the primary endpoint, while secondary endpoints were length of stay (LOS) in intensive care unit/hospital. Impact of individual studies and cumulative evidence reliability were evaluated with sensitivity analyses and trial sequential analysis, respectively. RESULTS: Six RCTs involving 963 patients published from 1999 to 2019 were included. In early postoperative period (i.e., 2 weeks), the use of intravenous lidocaine (overall incidence = 14.8%) was associated with a lower risk of cognitive deficit compared to that with placebo (overall incidence = 33.1%) (relative risk = 0.49, 95% confidence interval: 0.32–0.75). However, sensitivity analysis and trial sequential analysis signified insufficient evidence to arrive at a firm conclusion. In the late postoperative period (i.e., 6–10 weeks), perioperative intravenous lidocaine (overall incidence = 37.9%) did not reduce the risk of cognitive deficit (relative risk = 0.99, 95% confidence interval: 0.84) compared to the placebo (overall incidence = 38.6%). Intravenous lidocaine was associated with a shortened LOS in intensive care unit/hospital with weak evidence. CONCLUSION: Our results indicated a prophylactic effect of intravenous lidocaine against cognitive deficit only at the early postoperative period despite insufficient evidence. Further large-scale studies are warranted to assess its use for the prevention of cognitive deficit and enhancement of recovery (e.g., LOS). Lippincott Williams & Wilkins 2022-09-02 /pmc/articles/PMC9439840/ /pubmed/36107567 http://dx.doi.org/10.1097/MD.0000000000030476 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. |
spellingShingle | Research Article Hung, Kuo-Chuan Ho, Chun-Ning Liu, Wei-Cheng Yew, Ming Chang, Ying-Jen Lin, Yao-Tsung Hung, I-Yin Chen, Jen-Yin Huang, Ping-Wen Sun, Cheuk-Kwan Prophylactic effect of intravenous lidocaine against cognitive deficit after cardiac surgery: A PRISMA-compliant meta-analysis and trial sequential analysis |
title | Prophylactic effect of intravenous lidocaine against cognitive deficit after cardiac surgery: A PRISMA-compliant meta-analysis and trial sequential analysis |
title_full | Prophylactic effect of intravenous lidocaine against cognitive deficit after cardiac surgery: A PRISMA-compliant meta-analysis and trial sequential analysis |
title_fullStr | Prophylactic effect of intravenous lidocaine against cognitive deficit after cardiac surgery: A PRISMA-compliant meta-analysis and trial sequential analysis |
title_full_unstemmed | Prophylactic effect of intravenous lidocaine against cognitive deficit after cardiac surgery: A PRISMA-compliant meta-analysis and trial sequential analysis |
title_short | Prophylactic effect of intravenous lidocaine against cognitive deficit after cardiac surgery: A PRISMA-compliant meta-analysis and trial sequential analysis |
title_sort | prophylactic effect of intravenous lidocaine against cognitive deficit after cardiac surgery: a prisma-compliant meta-analysis and trial sequential analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439840/ https://www.ncbi.nlm.nih.gov/pubmed/36107567 http://dx.doi.org/10.1097/MD.0000000000030476 |
work_keys_str_mv | AT hungkuochuan prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis AT hochunning prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis AT liuweicheng prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis AT yewming prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis AT changyingjen prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis AT linyaotsung prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis AT hungiyin prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis AT chenjenyin prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis AT huangpingwen prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis AT suncheukkwan prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis |